Lower GI 2017

Clinical trials with EGFR-Inhibition in RC

Series

n

Treatment

pCR

RT + 5-FU + Cetuximab RT + Cape + Cetuximab RT + Capox+ Cetuximab RT + Capiri+ Cetuximab

Bertolini, 2007 40

8%

Machiels, 2007 30

5%

Rödel, 2008

48

9%

Hofheinz, 2008 50

8%